Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
11. Dezember 2024 06:05 ET
|
Serina Therapeutics, Inc.
HUNTSVILLE, AL, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...